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The emergence of the group B streptococci as significant and prevalent agents 
in  human  perinatal  and  neonatal  infections  is  relatively  recent  (1)  and  has 
stimulated renewed interest in the biology of these organisms.  However, their 
antigenic composition has been studied for several decades. Shortly after charac- 
terizing  this  serological  group  of streptococci  (2),  Lancefield  identified  three 
distinctive serotypes, I, II, and III, on the basis of specific carbohydrate (CHO) ~ 
antigens  (3)  and  subsequently  separated  type I  into  Ia and  Ib  (4).  Recently, 
Wilkinson  and  her  associates  have  identified  a  third  member  of the  type  I 
complex, type Ic, which is related to type Ia by the mutual possession of IaCHO 
and  to type Ib by the  presence  in both of Ibc protein  (5,  6).  All  three  type I 
serotypes share IabcCHO (7). Other cellular antigens of the group B streptococci 
have been defined,  (8) and some have been isolated and analyzed by immuno- 
chemical techniques  (9-13). 
This paper summarizes a series of experiments that were designed to develop 
a  quantitative  assay  of  phagocytosis  and  to  identify  the  critical  microbial 
antigens and serum requirements for the opsonization of group B streptococci. 
This report deals with streptococci of types Ia, Ib, and Ic and, to facilitate the 
presentation  and discussion of data,  Table I summarizes the principal  cellular 
antigens of these serotypes, as defined in the laboratories of Lancefield et al. (7) 
and of Wilkinson and Eagon (6). 
Materials  and  Methods 
Streptococcal Strains.  Prototype group B  streptococcal strains were provided by Dr.  R.  C. 
Lancefield: 090, type Ia; H36B, type Ib; A909,  type Ic; 18RS21,  type II; D136C,  type III. Working 
stocks were maintained on sheep blood agar at 4°C and subcultured at monthly intervals. 
Animals.  Adult, female, New Zealand albino rabbits (8-9 pounds) were used as a  source of 
normal rabbit  serum  (NRS)  and  antiserum.  Smaller  (6-7  pounds),  unsexed animals were the 
source of alveolar macrophages. 
Preparation ofAntisera.  Rabbits were immunized intravenously with formalin-killed strepto- 
cocci by the method of Lancefield (3). The injection scehdule was 0.5 ml of bacterial suspension on 3 
successive days followed at weekly intervals by 1.0 ml on 3 successive days. Immunizations were 
continued for 1 or 2 mo or until antisera demonstrated strong homologous reactions when set up 
* This work was supported by a  grant from the U. S.  Public Health Service (HD-07559). 
Abbreviations  used in this paper: CFU, colony-forming units; CHO, carbohydrate; FCS, fetal 
calf serum; NRS, normal rabbit serum. 
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TABLE  I 
Distribution of Cellular Antigens of Group B Streptococcal Types 
Ia, Ib, and Ic* 
Type-specific  Common carbohy-  Common protein 
Serotype  carbohydrate  drate 
Ia  IaCHO  IabcCHO  - 
Ib  IbCHO  IabcCHO  Ibc protein 
Ic  IaCHO  IabcCHO  Ibc protein 
* Based upon the reports of Lancefield et al. (7) and Wilkinson et al. (6). 
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with hot-acid extracts of all five prototype strains in an Ouchterlony double-diffusion test. Sera 
were absorbed with heat-killed streptococci in a proportion of 1 vol serum:l vol packed bacteria; 
these were mixed and left at room temperature for 18 h (14). Sera were studied unheated and after 
heating for 30 min in a  56°C water bath. 
Preparation of Radiolabeled  Streptococci.  2 tLCi/ml  of uniformly labeled L-|*4C]leucine (New 
England Nuclear,  Boston, Mass.) was added to 5 ml of RPMI medium no.  1640 without leucine 
(Grand Island Biological Co., Grand Island, N.  Y.). This was inoculated with 0.1  ml of an 18-h 
streptococcal broth culture (Todd-Hewitt, Difco Laboratories, Detroit, Mich.), incubated overnight 
at 37°C,  and harvested by centrifugation at  1,500 g  for 10  min.  The sedimented bacteria were 
washed three times with saline and suspended in the original volume of saline. After dilutions and 
pour plates were made to determine the number of colony-forming units (CFU), the streptococci 
were killed by heating at 60°C for 1 h.  Bacterial purity and killing were confirmed by culture. 
Suspensions of labeled streptococci were stored at 4°C, and the integrity of the labeled bacteria was 
checked at least weekly by centrifugation at 1,500g for 10 min; this consistently  precipitated >95% 
of counts per minute. 
Bacterial Phagocytosis  by Cultured  Alveolar  Macrophages.  The technique of Reynolds and 
Thompson  (15) was  modified by  the  use  of glass coverslips rather  than  plastic dishes as the 
supporting substrate for macrophages. This change obviated the removal of macrophages from 
substrate before scintillation counting and was considered valid if the majority of macrophages 
could be demonstrated to remain adherent and viable during incubation with serum and bacteria 
and subsequent washing. 
Rabbits were anesthetized with 60 mg of sodium pentobarbital intravenously and killed by air 
embolism.  Under  aseptic  conditions,  the  trachea  was  promptly  isolated,  cannulated  with  a 
pediatric endotracheal tube (Shiley Laboratories, Inc., Santa Ana, Calif.), and lavaged with four 
50-ml vol of saline. The alveolar macrophages were separated from this suspension by centrifuga- 
tion at 550 g  for 10 min and washed twice with 10 ml of modified McCoy's 5A medium containing 
10% fetal calf serum (FCS) (both purchased from Grand Island Biological Co.). The FCS had been 
heated at 56°C for 30 min and filtered through a Seitz asbestos filter (Scientific Products, Irvine, 
Calif.). Gentamicin sulfate (5 tLg/ml)  was added to all McCoy's medium to inhibit the growth of 
Bordetella  bronchiseptica,  a  contaminant of the lung washings in  approximately 50%  of these 
experiments. 
Short-range macrophage cultures were established on 10.5 x  22-mm glass cover-slips (Wheaton 
Scientific, Div.  Wheaton Industries, Millville, N. J.) in 13  ×  125-mm siliconized Leighton tubes. 
Coverslips were precleaned and coated with poly-L-lysine (Sigma Chemical Co., St. Louis, Mo.) to 
enhance cell adherence (16).  Macrophages were counted in a hemocytometer, and approximately 
10  ~ in 1 ml of McCoy's medium with 25% FCS was added to each coverslip. The tubes were loosely 
stoppered and incubated at 37°C in 5% COx for approximately 18 h, at which time the medium was 
decanted from all tubes and the coverslips washed three times with McCoy's medium containing 
10%  FCS.  For  each set of macrophage cultures from a  single animal,  the  number of viable, 
adherent cells per tube was estimated by treating one or two coverslips with 1 ml of 0.25% trypsin 
in phosphate-buffered  saline, pH 7.4, diluting the trypsin-cell suspension with 0.2% trypan blue in 
a  leukocyte pipette and counting in a  hemocytometer. 20-50%  (2-5  x  10:' per coverslip) of the 
original macrophage inoculum could be recovered and >99% of the adherent cells were viable as 
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An appropriate dilution of labeled streptococci was mixed with an equal volume of a  1:5 dilution 
of NRS or antiserum (both in McCoy's medium with 10% FCS) and incubated in a 37°C water bath 
for 10 min. 0.1 ml of the bacteria-serum mixtures and 0.9 ml of McCoy's medium with 10% FCS 
were then added to each coverslip for a bacterial CFU:macrophage ratio of 100:1, and the Leighton 
tubes were agitated gently at 37°C on a rocking platform (Bellco Glass, Inc., Vineland, N. J.). At 0, 
30, 60, and 120 min, a  number of coverslips were washed three times with McCoy's medium and 
10%  FCS to  remove free bacteria,  air dried,  and immersed in scintillation vials to determine 
radioactive uptake by macrophages. At 120 rain one or two additional coverslips were trypsinized 
and the trypsin-cell suspension counted in the presence of trypan blue to rule out excessive loss of 
macrophages during the experiment. For all experiments reported here,  ->90% of the originally 
adherent  cells  survived.  Scintillation fluid  consisted  of equal  volumes  of toluene  (Matheson, 
Coleman &  Bell, Rutherford, N. J.) and Permablend II (Packard Instrument Co. Inc., Downers 
Grove, Ill.), and counts per minute were determined in duplicate in a  Nuclear-Chicago Mark II 
Liquid  Scintillation  Counter  (G.  D.  Searle  and  Co.,  Des  Plaines,  Ill.).  The  extent  of  each 
phagocytosis experiment was  limited by the quantity of macrophages recovered from a  single 
rabbit and hence the number of coverslip cultures.  Therefore,  it was  not possible to  evaluate 
opsonization of each streptococcal strain by all sera in a single experiment. However, all results 
reported here were confirmed in additional experiments which are not shown. 
Microscopy.  At the end of phagocytosis experiments, some coverslips were washed, air dried, 
treated with Wright's stain, mounted on glass slides, and examined under oil immersion with a 
Zeiss photomicroscope (Carl Zeiss,  Inc.,  New  York).  Photomicrographs were made with Koda- 
chrome II professional film (Eastman Kodak Co., Rochester, N.  Y.). 
Bacterial Killing by Macrophage Suspension.  This was assessed by micromodification of the 
method  of Quie  et  al.  (17).  An  overnight broth  culture  of unlabeled streptococci  and freshly 
harvested alveolar macrophages were  washed and suspended in Hanks' balanced salt solution 
with 1% gelatin. Similar concentrations of CFU and macrophages (3-4  ×  10e/ml) and 4% NRS or 
antiserum in a  total vol of 0.5 ml were tumbled in 12  x  75-mm plastic tubes with snap closures 
(Falcon Plastics, Div. of Bioquest, Oxnard, Calif.) at approximately 12 rpm on a rotator (Scientific 
Instruments, Inc., St. Lake Worth, Fla.). CFU were counted at 0, 15, 30, and 60 min by a standard 
dilution and pour  plate  method.  In  experiments reported  here,  the  macrophages  were  free of 
contamination by B. bronchiseptica. 
Results 
Uptake of Radioactivity by Macrophages.  Fig. I illustrates an experiment in 
which radiolabeled,  killed streptococci of type Ia, after exposure to unabsorbed 
rabbit  sera,  were  incubated  with  coverslip  cultures  of alveolar  macrophages. 
There  was  progressive  and  significant  uptake  of counts  per  minute  by  the 
cultures when the bacteria had been incubated with unheated or heated, unab- 
sorbed serum to type Ia, no significant uptake after exposure to NRS or antise- 
rum to types II and III, and minimal uptake after incubation with unabsorbed 
type Ib serum.  Moreover,  coverslips without macrophages  did not accumulate 
radioactivity  when  incubated  with  labeled  bacteria  exposed  to  homologous 
antiserum; this last control was regularly included in all experiments but does 
not appear in subsequent figures. 
When stained coverslips were examined under light microscopy, macrophages 
that  had  been  incubated  with  streptococci  exposed  to  specific  antiserum  ap- 
peared to contain numerous cocci (Fig. 2 A), but cultures incubated with bacte- 
ria treated with NRS did not (Fig.  2 B). 
Evidence  that  Uptake  of Radioactivity  was a Quantitative  Measurement of 
Phagocytosis.  The attachment of complexes of labeled streptococci and immu- 
noglobulin  G  antibody to Fc binding sites on the  membranes  of macrophages 
without significant ingestion of bacteria could result in the uptake of counts per a. 
c.) 
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Fro.  1.  Uptake by macrophage cultures of radiolabeled type Ia streptococci preincubated 
with various unabsorbed rabbit sera. 
minute by coverslip cultures and might be difficult to exclude with certainty by 
light microscopy. Therefore, the following experiments were conducted. 
After brief incubation  at 37°C,  appropriate  mixtures  of labeled streptococci 
and specific antiserum were chilled and added to macrophage cultures in Leigh- 
ton tubes which rested on an ice slurry. These were rocked alongside unchilled 
tubes  in  the  37°C  incubator.  Chilling  is  known  to  inhibit  ingestion  but  not 
attachment  of immune  complexes to macrophage  membranes  (18).  As Fig.  3 
shows,  this procedure reduced the uptake  of radioactivity by over 90%  of the 
uptake at 37°C.  When the chilled cultures were again warmed (Fig. 3, arrow), 
the usual uptake of counts per minute occurred over the next 2 h, indicating that 
inhibition by cold was reversible. Moreover, microscopic examination of phago- 
cytic mixtures  which  had  been rocked  on  ice  for  2  h  suggested  considerable 
peripheral  accumulation  but little interiorization  of bacteria  (Fig.  2 C).  These 
data indicate that the uptake of radioactivity was largely due to phagocytosis of 
streptococci. 
Additional,  indirect  evidence  for  phagocytosis  was  provided  by  studies  of 1190  IMMUNITY  TO  GROUP  B  STREPTOCOCCI 
FIG.  2.  Photomicrographs of cultured macrophages after incubation with type Ia strepto- 
cocci.  (A)  Incubation  at 37°C  with streptococci  preincubated  with type Ia serum  and  (B) 
NRS. (C) Incubation on ice with streptococci  preincubated with type Ia serum.  × 950. 
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Fro.  3.  Uptake by macrophage cultures of radiolabeled type Ia streptococci  at 37°C (bro- 
ken lines) and on ice (solid line). The arrow indicates point at which chilled cultures were 
returned to 37°C  environment. 
streptococcal killing. It was necessary to perform these experiments with freshly 
collected macrophages in suspension,  rather than with cultured macrophages. 
Nevertheless,  as shown in Fig.  4,  approximately 90% of the original bacterial 
inoculum was killed by suspended macrophages in the presence of the specific, 
homologous  antiserum  which  also  promoted  ma£imal  uptake  of counts  per 
minute by cultured macrophages. 
Opsonization and Phagocytosis of Type Ia (Fig. 5).  The uptake of radioactiv- 
ity by macrophages was maximal after preincubation of  type Ia streptococci with 
unabsorbed  homologous  serum,  insignificant  after  incubation  with  NRS  or l0 s - 
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Fro.  4.  Killing of type Ia streptococci by various combinations of suspended macrophages 
and sera. 
unabsorbed  sera  to types II  and  III,  and  intermediate  after incubation  with 
unabsorbed type Ib serum (Fig. 5 A). The effect of type Ia serum was apparently 
related to antibody to IaCHO, since it was unaffected by absorption with type Ib 
cells, but completely inactivated by absorption with cells of type Ia or type Ic, 
both of which contain IaCHO (Fig. 5 A). Similarly, the maximal opsonic activity 
of type Ic serum and the results of absorption with the three subtypes (Fig. 5 B) 
could be attributed to anti-IaCHO.  On the other hand, the intermediate effect of 
type Ib serum, which was completely absorbed by cells of type Ia, Ib, or Ic, was 
apparently due to antibody to IabcCHO (Fig.  5 A). 
Opsonization  and Phagocytosis of Type Ib (Fig. 6).  The finding with type Ib 
complemented the previous observations with type Ia streptococci in that phago- 
cytosis was  greatest  after  opsonization  with  homologous  antiserum,  neglible 
with  NRS  or  unabsorbed  serum  to  type  II  or  type  III,  and  moderate  with 
unabsorbed type Ia serum (Fig.  6 A). The absorption studies shown in Fig. 6 B 
indicated that the strong homologous reaction was related to antibody to IbCHO 
and the moderate opsonic activity of type Ia serum to anti-IabcCHO.  However, 
the effect of unabsorbed type Ic antiserum  (Fig.  6 C),  resulting  in phagocytic 
uptake  equal  to that  produced by type Ib serum,  was largely  attributable  to 
antibody to Ibc protein, since it was completely absorbed by either type Ib or Ic. 
It is possible that some opsonic activity of this serum was due to anti-IabcCHO, 
since there was partial removal with type Ia cells. 1192 
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Opsonization and Phagocytosis of Type Ic (Fig.  7).  Phagocytosis of type Ic 
was equally significant after exposure to unabsorbed serum against type Ia, Ib, 
or Ic, insignificant after exposure to NRS or unabsorbed type II serum (Fig. 7 A), 
and intermediate after exposure to unabsorbed type III serum (Fig.  7 B).  The 
absorption studies shown in Fig. 7 A indicated that the activity of type Ia serum 
was due  entirely to  anti-IaCHO,  and the  activity of type Ib  serum was due 
largely to anti-Ibc protein. Some of the latter may also be attributable to anti- 
IabcCHO since there was partial absorption by type Ia (Fig. 7 A).  The effect of 
type III serum and its absorption by three heterologous strains (Fig. 7 B) were 
presumably related to antibody to an unidentified antigen common to all group 
B streptococcal serotypes. 
Fig. 7 C illustrates the antigen-antibody systems involved in the opsonization 
of type Ic by homologous antiserum. The opsonic effect of this serum was not 
significantly affected by  absorption  with  streptococci  of either type Ia  or  Ib 
alone. However, sequential absorption with cells of both serotypes removed all 
activity, as did absorption with type Ic. This serum was similarly absorbed with 
cells of types Ib and II to rule out nonspecific removal of essential serum opsonic 
factors by sequential treatment with two serotypes (Fig. 7 C). Thus, antiserum 
to type Ic streptococci appeared to contain at least two populations of opsonic 
antibody, anti-IaCHO and anti-Ibc protein,  either of which effected maximal 
phagocytosis alone. 
Heat-Stability of Serum Opsonins.  As shown in Fig. 1, 4, 5A, 6A, and 7A, 
heating of serum at 56°C for 30 min had no significant influence on the opsonic 
effect of sera  against  the  homologous serotypes.  In  addition,  maximal  and BASCOM  F.  ANTHONY  1193 
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intermediate levels of opsonic activity against heterologous serotypes were not 
modified by heating. 
Discussion 
The most definitive evidence regarding immunity to the group B streptococci 
is derived from studies in mice of virulence and protection by rabbit antiserum. 
Thus, Lancefield and associates have demonstrated protection against group B 
streptococci by a  number of specific antibodies.  Anti-IaCHO was shown to be 
protective against type Ia infection and anti-IbCHO against type Ib (4).  Anti- 
IabcCHO, apparently present only in certain sera,  was protective for infection 
with  types  Ia,  Ib,  or  Ic  (4,  7).  Recently,  anti-Ibc  protein  was  shown  to  be 
protective against types Ib and Ic (7).  Antibody to type II CHO is also mouse 
protective for the corresponding serotype (9), but direct evidence regarding type 
III and the significance of the other defined antigens of the group B cell wall is 
lacking (7, 8). Antibody to the group B CHO is apparently not protective (7). 
Inasmuch as the ultimate defense of the host against most invasive bacteria is 
phagocytosis, the studies reported here were focused on the in vitro interaction 
of bacteria,  serum,  and  macrophages  in  an  attempt  to  analyze  the bacterial 
antigens and serum factors critical to the opsonization of group B streptococci. 
The assay method used here was shown to measure phagocytosis quantitatively 
and reproducibly and offers some advantages over other in vitro methods. The 
indirect bactericidal test has been used extensively for group A streptococci (19), 
but proved to be difficult in these studies because multiplication of the group B 
organisms in the blood of most human donors studied was inconsistent. Another 
technique  (17) has been used widely and successfully to study the phagocytosis 
and intracellular killing of various bacteria. However, these two events are not 
easily separable, and results with this method were not always clear cut. This 
may have been the result of multiplication  by extracellular  bacteria,  even in 
phagocytic mixtures in which significant ingestion and killing occurred. The use 
of radiolabeled,  nonreplicating  bacteria  and  cultured  alveolar  macrophages 
appeared to avoid some of these technical difficulties. 
This  study  demonstrates  the  absolute  requirement  of specific  antibody  to 
bacterial  antigens,  type-specific  or  shared,  CHO  or  protein,  for  significant 
phagocytosis of group B streptococci of types Ia, Ib, and Ic. It is noteworthy that 
the IaCHO, IbCHO, and Ibc protein antigen-antibody systems were consistently 
associated with significantly greater phagocytosis than the IabcCHO system. It 
is not clear whether the subsidiary opsonic role of the latter is simply the result 
of smaller amounts of cross-reacting anti-IabcCHO or is inherent in the struc- 
ture,  quantity,  location,  or  steric  arrangement  in  the  bacterial  cell  wall  of 
IabcCHO in relation to other surface antigens. 
Type  Ic  streptococci  differ  from  types  Ia  and  Ib  in  the  possession  of two 
antigens of major importance in opsonization.  Maximal phagocytosis of type Ic 
followed treatment with the homologous serum,  as well as with type Ia serum 
(presumably due to anti-IaCHO) or type Ib serum (presumably anti-Ibc protein). 
Type Ic serum appeared to contain both antibodies, since absorption with both Ia 
and Ib cells was required to abolish its opsonic activity. 
One finding that  could not be explained  by the  known scheme of bacterial 1196  IMMUNITY  TO  GROUP  B  STREPTOCOCCI 
antigens was the intermediate opsonic octivity of unabsorbed type III serum on 
type Ic streptococci. Although the Ibc protein is found sometimes in type H (20) 
and rarely in type III (J. Jelinkova, personal communication), anti-Ibc protein, 
as the source of this activity, was excluded by absorption with any of the group B 
serotypes. Therefore, this serum was opsonic for type Ic apparently because of 
antibody to an unidentified antigen common to all prototype strains. 
The  heat  stability  of rabbit  serum  opsonins  for  group  B  streptococci  was 
striking  and  is  of interest  in  view of the  opsonic  requirements  for  group  A 
streptococci which,  in the presence of either human antibody or hyperimmune 
rabbit serum, include complement and possibly other heat labile serum factors 
(21-23). In addition, available data suggest that the opsonic activity for group B 
streptococci present in some human sera is heat labile but not clearly related to 
complement components (24,  25). 
The  state  of human  immunity  to the  group B  streptococci is largely  unex- 
plored and is a question of potential significance, particularly in pregnancy and 
the newborn period. In a  study limited to a single group B strain of unspecified 
serotype,  Dossett  et  al.  demonstrated  low  but  comparable  levels  of opsonic 
activity in maternal  and cord sera  (26).  Basing their conclusions upon micro- 
scopic examination  of neutrophiles after incubation  with group B  streptococci 
and serum, Klesius et al. reported that parturient women and their infants have 
serum opsonins against types Ib, Ic, II, and III, but not against type Ia strepto- 
cocci (24). There is a need to confirm and extend these observations as a possible 
means of prospectively identifying pregnancies and newborn infants at special 
risk of serious infection with the group B streptococci. 
Summary 
The opsonization and phagocytosis of group B streptococci of types Ia, Ib, and 
Ic were studied in vitro by measuring the uptake of radioactivity by coverslip 
cultures of rabbit alveolar macrophages during  incubation  with radiolabeled, 
nonviable  bacteria  which  had  been  exposed to  rabbit  serum.  The  uptake  of 
counts per minute was quantitative,  reproducible,  and reversibly inhibited by 
cold,  indicating  that  it  was  largely  a  measurement  of phagocytic  ingestion 
rather  than  of attachment  of bacteria-immunoglobulin  complexes  to  macro- 
phage  membranes.  Moreover,  suspended  macrophages  killed  approximately 
90% of viable streptococci in the presence of specific antiserum. 
The opsonic activity of immune serum was heat stable,  and phagocytosis of 
streptococci was insignificant  after incubation with normal  serum and antise- 
rum to some heterologous group B  streptococci.  By absorption studies,  it was 
possible to identify the effect of antibodies to specific bacterial antigens. Phago- 
cytosis of streptococci containing the corresponding antigens was maximal after 
opsonization  with  homologous  or  heterologous  sera  containing  antibody  to 
IaCHO, IbCHO, or Ibc protein. Phagocytosis of all three serotypes was interme- 
diate when opsonization could be attributed to anti-IabcCHO. The opsonization 
of a  specific group  B  streptococcus is  complex and  may involve two or  more 
antigen-antibody systems. 
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